Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Am J Transplant. 2013 May 1;13(6):1523–1532. doi: 10.1111/ajt.12234

Table 2.

Risk of plasma cell neoplasms according to demographic characteristics and transplanted organ

Characteristic N Incidence* SIR 95% lower limit 95% upper limit P-value for heterogeneity in SIRs
Sex 0.25
 Female 36 9.9 1.55 1.09 2.15
 Male 104 18.9 1.90 1.55 2.30
Age at transplant, years 0.03
 0–34 7 3.0 8.19 3.29 16.87
 35–49 30 9.8 2.36 1.59 3.37
 50–64 79 25.4 1.69 1.33 2.10
 65+ 24 40.6 1.37 0.88 2.04
Race/ethnicity 0.04
 White 97 16.4 2.01 1.63 2.45
 Black 23 17.2 1.25 0.79 1.88
 Hispanic 13 9.6 1.43 0.76 2.45
 Asian/Pacific Islander 7 14.0 3.19 1.28 6.57
Transplanted organ 0.25
 Kidney 82 15.6 1.88 1.50 2.34
 Liver 22 10.9 1.29 0.81 1.96
 Heart 30 27.2 2.27 1.53 3.25
 Lung 2 7.2 0.86 0.10 3.09
 Other 4 8.4 2.26 0.61 5.77
HLA mismatch 0.26
 0–2 28 15.2 2.10 1.39 3.03
 3–4 44 13.2 1.51 1.10 2.03
 5–6 51 18.8 2.03 1.51 2.67

Notes

Abbreviations: SIR standardized incidence ratio

*

Incidence rate is per 100,000 person-years.

Subjects with missing data on HLA mismatch were excluded from this analysis.